![](/img/cover-not-exists.png)
Adjuvant ribavirin and longer direct‐acting antiviral treatment duration improve sustained virological response among hepatitis C patients at risk of treatment failure
Lu, Mei, Wu, Kuan‐Han, Li, Jia, Moorman, Anne C., Spradling, Philip R., Teshale, Eyasu H., Boscarino, Joseph A., Daida, Yihe G., Schmidt, Mark A., Rupp, Loralee B., Zhang, Talan, Trudeau, Sheri, GordoLanguage:
english
Journal:
Journal of Viral Hepatitis
DOI:
10.1111/jvh.13162
Date:
June, 2019
File:
PDF, 752 KB
english, 2019